Cargando…

miRNA-223 is an anticancer gene in human non-small cell lung cancer through the PI3K/AKT pathway by targeting EGFR

The present study aimed to further explore the molecular mechanisms of miRNA-223 in non-small cell lung cancer (NSCLC). Data prospectively collected from NSCLC patients and volunteers from March 2016 to May 2016 at Tsinghua Changgung Hospital were analyzed. Cell proliferation was measured using MTT...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ma, Hui-Ping, Kong, Wei-Xiang, Li, Xiu-Ying, Li, Wei, Zhang, Yan, Wu, Yan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2019
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6365711/ https://www.ncbi.nlm.nih.gov/pubmed/30747217 http://dx.doi.org/10.3892/or.2019.6983

Ejemplares similares

miR-223 reverses the resistance of EGFR-TKIs through IGF1R/PI3K/Akt signaling pathway
por: HAN, JING, et al.
Publicado: (2016)

Associations of miRNA-146a and miRNA-223 with Rheumatoid Arthritis and Their Predictive Values
por: Zhang, Haoshaqiang, et al.
Publicado: (2023)

Small‐molecule nanoprodrug with high drug loading and EGFR, PI3K/AKT dual‐inhibiting properties for bladder cancer treatment
por: Li, Guoyin, et al.
Publicado: (2023)

MiR-1299 Impedes the Progression of Non-Small-Cell Lung Cancer Through EGFR/PI3K/AKT Signaling Pathway
por: Cao, Shengya, et al.
Publicado: (2020)

MiRNA-132 regulates the development of osteoarthritis in correlation with the modulation of PTEN/PI3K/AKT signaling
por: Zhang, Wei, et al.
Publicado: (2021)

miRNA-186 Improves Sepsis Induced Renal Injury Via PTEN/PI3K/AKT/P53 Pathway
por: Li, Min, et al.
Publicado: (2020)

Anticancer effect of the traditional Chinese medicine herb Maytenus compound via the EGFR/PI3K/AKT/GSK3β pathway
por: Zeng, Baozhen, et al.
Publicado: (2019)

Cyclooxygenase-2 mediates gefitinib resistance in non-small cell lung cancer through the EGFR/PI3K/AKT axis
por: Deng, Qin-fang, et al.
Publicado: (2020)

miRNA-21 and miRNA-223 expression signature as a predictor for lymph node metastasis, distant metastasis and survival in kidney renal clear cell carcinoma
por: Yu, Li, et al.
Publicado: (2018)

Bta-miR-223 Targeting CBLB Contributes to Resistance to Staphylococcus aureus Mastitis Through the PI3K/AKT/NF-κB Pathway
por: Han, Shuo, et al.
Publicado: (2020)

Exosomal miRNA-223-3p as potential biomarkers in patients with cerebral small vessel disease cognitive impairment
por: Zhao, Weina, et al.
Publicado: (2021)

Differential Expression of miRNA-223 in Coronary In-Stent Restenosis
por: Ganjali, Shiva, et al.
Publicado: (2022)

Digoxin exerts anticancer activity on human nonsmall cell lung cancer cells by blocking PI3K/Akt pathway
por: Wang, Yingying, et al.
Publicado: (2021)

SCD1 is required for EGFR-targeting cancer therapy of lung cancer via re-activation of EGFR/PI3K/AKT signals
por: She, Kelin, et al.
Publicado: (2019)

TUC338 Promotes Diffuse Large B Cell Lymphoma Growth via Regulating EGFR/PI3K/AKT Signaling Pathway
por: Li, Yan, et al.
Publicado: (2021)

The PI3K/AKT signaling pathway: Associations of miRNAs with dysregulated gene expression in colorectal cancer
por: Slattery, Martha L., et al.
Publicado: (2017)

miRNA-223 is a potential diagnostic and prognostic marker for osteosarcoma
por: Dong, Junbo, et al.
Publicado: (2016)

Celecoxib enhances anticancer effect of cisplatin and induces anoikis in osteosarcoma via PI3K/Akt pathway
por: Liu, Bing, et al.
Publicado: (2017)

LncZEB1-AS1 regulates hepatocellular carcinoma bone metastasis via regulation of the miR-302b-EGFR-PI3K-AKT axis
por: Ma, Zhen-jiang, et al.
Publicado: (2020)

Anticancer Effects of Paris Saponins by Apoptosis and PI3K/AKT Pathway in Gefitinib-Resistant Non-Small Cell Lung Cancer
por: Zhu, Xinhai, et al.
Publicado: (2016)

Targeting EGFR/PI3K/AKT/mTOR Signaling in Hepatocellular Carcinoma
por: Bang, Jieun, et al.
Publicado: (2023)

Down-Regulation of MicroRNA-223 Promotes Degranulation via the PI3K/Akt Pathway by Targeting IGF-1R in Mast Cells
por: Wang, Quan, et al.
Publicado: (2015)

miR-7 reverses the resistance to BRAFi in melanoma by targeting EGFR/IGF-1R/CRAF and inhibiting the MAPK and PI3K/AKT signaling pathways
por: Sun, Xiaoyan, et al.
Publicado: (2016)

Increased Circulating Exosomal miRNA-223 Is Associated with Acute Ischemic Stroke
por: Chen, Yajing, et al.
Publicado: (2017)

MiR-223 Regulates Human Embryonic Stem Cell Differentiation by Targeting the IGF-1R/Akt Signaling Pathway
por: Yu, Yan-Hui, et al.
Publicado: (2013)

The Yunnan national medicine Maytenus compound inhibits the proliferation of hepatocellular carcinoma (HCC) by suppressing the activation of the EGFR-PI3K-AKT signaling pathway
por: Zhao, Wen-Tao, et al.
Publicado: (2021)

Plasma miRNA-223 correlates with risk, inflammatory markers as well as prognosis in sepsis patients
por: Wu, Xiaoling, et al.
Publicado: (2018)

miRNA-197 and miRNA-223 Predict Cardiovascular Death in a Cohort of Patients with Symptomatic Coronary Artery Disease
por: Schulte, Christian, et al.
Publicado: (2015)

SKA3 promotes lung adenocarcinoma metastasis through the EGFR–PI3K–Akt axis
por: Hu, Dan-dan, et al.
Publicado: (2020)

MiR-29c reduces the cisplatin resistance of non-small cell lung cancer cells by negatively regulating the PI3K/Akt pathway
por: Sun, Dian-min, et al.
Publicado: (2018)

miRNA-103 promotes chondrocyte apoptosis by down-regulation of Sphingosine kinase-1 and ameliorates PI3K/AKT pathway in osteoarthritis
por: Li, Fang, et al.
Publicado: (2019)

Potential Use of Anti-Cancer Drugs for Treatment of Preeclampsia by Targeting the miRNA-IGF1R-PI3K-AKT Axis
por: Li, Jieyan, et al.
Publicado: (2022)

miRNA-125a modulates autophagy of thyroiditis through PI3K/Akt/mTOR signaling pathway
por: Chen, Danyan, et al.
Publicado: (2019)

Syringin exerts anti-breast cancer effects through PI3K-AKT and EGFR-RAS-RAF pathways
por: Wang, Fei, et al.
Publicado: (2022)

MiR‐3116 sensitizes glioma cells to temozolomide by targeting FGFR1 and regulating the FGFR1/PI3K/AKT pathway
por: Kong, Shiqi, et al.
Publicado: (2020)

MiRNA-21 mediates the antiangiogenic activity of metformin through targeting PTEN and SMAD7 expression and PI3K/AKT pathway
por: Luo, Mao, et al.
Publicado: (2017)

Auranofin-mediated inhibition of PI3K/AKT/mTOR axis and anticancer activity in non-small cell lung cancer cells
por: Li, Hongyu, et al.
Publicado: (2015)

miR-223: An Effective Regulator of Immune Cell Differentiation and Inflammation
por: Jiao, Peng, et al.
Publicado: (2021)

MicroRNA-1231 exerts a tumor suppressor role through regulating the EGFR/PI3K/AKT axis in glioma
por: Zhang, Jiale, et al.
Publicado: (2018)

Proliferation, migration and invasion of triple negative breast cancer cells are suppressed by berbamine via the PI3K/Akt/MDM2/p53 and PI3K/Akt/mTOR signaling pathways
por: Liu, Lili, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_hdpi3iulnabbcecari2vak8ei8